NovoCure (038.F) Q3 2024 Earnings

25JulConfirmed
Q4 2023
Q1 2024
Q3 2024
-0.48
-0.42
-0.35
-0.29

Details

Expected EPS
-0.37126898263
Actual EPS
-0.2856929
Surprise EPS
0.09
Surprise Percent
+23.05%

Description

NovoCure (038.F) has reported earnings of -0.2856929 per share for Q3 2024.

0 Comments

Share your thoughts